IRIS Accounts Production v25.4.0.155 09826810 Board of Directors 31.3.25 1.4.24 31.3.25 31.3.25 Medium entities These accounts have been prepared in accordance with the provisions applicable to companies subject to the medium-sized companies regime. true true true false true true false false false false false false false false false false false false false false false false false false false false false true false Ordinary 0 Ordinary E 0 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh098268102024-03-31098268102025-03-31098268102024-04-012025-03-31098268102023-03-31098268102023-04-012024-03-31098268102024-03-3109826810ns15:EnglandWales2024-04-012025-03-3109826810ns14:PoundSterling2024-04-012025-03-3109826810ns10:Director12024-04-012025-03-3109826810ns10:Consolidated2025-03-3109826810ns10:ConsolidatedGroupCompanyAccounts2024-04-012025-03-3109826810ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3109826810ns10:Consolidatedns10:MediumEntities2024-04-012025-03-3109826810ns10:Consolidatedns10:Audited2024-04-012025-03-3109826810ns10:Medium-sizedCompaniesRegimeForDirectorsReport2024-04-012025-03-3109826810ns10:Medium-sizedCompaniesRegimeForAccounts2024-04-012025-03-3109826810ns10:Consolidated2024-04-012025-03-3109826810ns10:Consolidatedns10:Medium-sizedCompaniesRegimeForDirectorsReport2024-04-012025-03-3109826810ns10:Medium-sizedCompaniesRegimeForAccountsns10:Consolidated2024-04-012025-03-3109826810ns10:FullAccounts2024-04-012025-03-3109826810ns5:Subsidiary12024-04-012025-03-3109826810ns5:Subsidiary22024-04-012025-03-3109826810ns5:Subsidiary32024-04-012025-03-3109826810ns5:Subsidiary42024-04-012025-03-3109826810ns5:Subsidiary52024-04-012025-03-3109826810ns5:Subsidiary62024-04-012025-03-3109826810ns5:Subsidiary72024-04-012025-03-3109826810ns5:Subsidiary82024-04-012025-03-3109826810ns5:Subsidiary92024-04-012025-03-3109826810ns5:Subsidiary102024-04-012025-03-3109826810ns5:Subsidiary112024-04-012025-03-3109826810ns5:Subsidiary122024-04-012025-03-3109826810ns5:Subsidiary132024-04-012025-03-3109826810ns5:Subsidiary142024-04-012025-03-3109826810ns5:Subsidiary152024-04-012025-03-3109826810ns5:Subsidiary162024-04-012025-03-3109826810ns5:Subsidiary172024-04-012025-03-3109826810ns5:Subsidiary182024-04-012025-03-310982681012024-04-012025-03-3109826810ns10:OrdinaryShareClass12024-04-012025-03-3109826810ns10:OrdinaryShareClass22024-04-012025-03-3109826810ns10:Director22024-04-012025-03-3109826810ns10:Director32024-04-012025-03-3109826810ns10:Director42024-04-012025-03-3109826810ns10:Director52024-04-012025-03-3109826810ns10:RegisteredOffice2024-04-012025-03-3109826810ns10:Consolidated2023-04-012024-03-3109826810ns5:CurrentFinancialInstruments2025-03-3109826810ns5:CurrentFinancialInstruments2024-03-3109826810ns5:Non-currentFinancialInstruments2025-03-3109826810ns5:Non-currentFinancialInstruments2024-03-3109826810ns5:ShareCapital2025-03-3109826810ns5:ShareCapital2024-03-3109826810ns5:SharePremium2025-03-3109826810ns5:SharePremium2024-03-3109826810ns5:RetainedEarningsAccumulatedLosses2025-03-3109826810ns5:RetainedEarningsAccumulatedLosses2024-03-3109826810ns5:ShareCapital2023-03-3109826810ns5:RetainedEarningsAccumulatedLosses2023-03-3109826810ns5:SharePremium2023-03-3109826810ns5:RetainedEarningsAccumulatedLosses2023-04-012024-03-3109826810ns5:ShareCapital2024-04-012025-03-3109826810ns5:SharePremium2024-04-012025-03-3109826810ns5:RetainedEarningsAccumulatedLosses2024-04-012025-03-310982681012024-04-012025-03-3109826810ns5:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3109826810ns5:ComputerSoftware2024-04-012025-03-3109826810ns5:OwnedOrFreeholdAssetsns5:LandBuildings2024-04-012025-03-3109826810ns5:LeaseholdImprovements2024-04-012025-03-3109826810ns5:PlantMachinery2024-04-012025-03-3109826810ns5:FurnitureFittings2024-04-012025-03-3109826810ns5:MotorVehicles2024-04-012025-03-3109826810ns5:ComputerEquipment2024-04-012025-03-3109826810ns5:ComputerSoftware2024-03-3109826810ns5:ComputerSoftware2025-03-3109826810ns5:ComputerSoftware2024-03-3109826810ns5:ComputerEquipment2024-03-3109826810ns5:ComputerEquipment2025-03-3109826810ns5:ComputerEquipment2024-03-3109826810ns5:CostValuation2024-03-31098268101ns5:Subsidiary12024-04-012025-03-3109826810ns5:Subsidiary232024-04-012025-03-31098268105ns5:Subsidiary32024-04-012025-03-3109826810ns5:Subsidiary472024-04-012025-03-31098268109ns5:Subsidiary52024-04-012025-03-3109826810ns5:Subsidiary6112024-04-012025-03-310982681013ns5:Subsidiary72024-04-012025-03-3109826810ns5:Subsidiary8152024-04-012025-03-310982681017ns5:Subsidiary92024-04-012025-03-310982681019ns5:Subsidiary102024-04-012025-03-310982681021ns5:Subsidiary112024-04-012025-03-310982681023ns5:Subsidiary122024-04-012025-03-310982681025ns5:Subsidiary132024-04-012025-03-3109826810ns5:Subsidiary14272024-04-012025-03-3109826810ns5:Subsidiary15292024-04-012025-03-3109826810ns5:Subsidiary16312024-04-012025-03-310982681032ns5:Subsidiary172024-04-012025-03-3109826810ns5:Subsidiary18332024-04-012025-03-3109826810ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3109826810ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3109826810ns5:DeferredTaxation2024-03-3109826810ns5:DeferredTaxation2024-04-012025-03-3109826810ns5:DeferredTaxation2025-03-3109826810ns10:OrdinaryShareClass12025-03-3109826810ns10:OrdinaryShareClass22025-03-3109826810ns5:RetainedEarningsAccumulatedLosses2024-03-3109826810ns5:SharePremium2024-03-31
REGISTERED NUMBER: 09826810 (England and Wales)















GROUP STRATEGIC REPORT,

REPORT OF THE DIRECTORS AND

CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

FOR

TRISTONE HEALTHCARE LIMITED

TRISTONE HEALTHCARE LIMITED (REGISTERED NUMBER: 09826810)

CONTENTS OF THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025










Page

Company Information 1

Group Strategic Report 2

Report of the Directors 12

Report of the Independent Auditors 14

Consolidated Income Statement 18

Consolidated Other Comprehensive Income 19

Consolidated Balance Sheet 20

Company Balance Sheet 21

Consolidated Statement of Changes in Equity 22

Company Statement of Changes in Equity 23

Consolidated Cash Flow Statement 24

Notes to the Consolidated Cash Flow Statement 25

Notes to the Consolidated Financial Statements 26


TRISTONE HEALTHCARE LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2025







DIRECTORS: Y A Loucopoulos
C Elliott
R Finney
P N Ledgard
A Hibbard





REGISTERED OFFICE: 5 Brooklands Place
Brooklands Road
Sale
Cheshire
M33 3SD





REGISTERED NUMBER: 09826810 (England and Wales)





AUDITORS: Harold Sharp Limited
Statutory Auditors and Chartered Accountants
5 Brooklands Place
Brooklands Road
Sale
Cheshire
M33 3SD

TRISTONE HEALTHCARE LIMITED (REGISTERED NUMBER: 09826810)

GROUP STRATEGIC REPORT
FOR THE YEAR ENDED 31 MARCH 2025


The directors present their strategic report of the company and the group for the year ended 31 March 2025.


TRISTONE HEALTHCARE LIMITED (REGISTERED NUMBER: 09826810)

GROUP STRATEGIC REPORT
FOR THE YEAR ENDED 31 MARCH 2025

REVIEW OF BUSINESS
Operational highlights

as at 31 March 2025 as at 31 March 2024
Capacity (places)
Adult residential service 56 48
Adult community care 53 46
Children residental services 124 101
Total 233 195

Occupancy (places)
Adult residential service 49 46
Adult community care 52 46
Children residental services 81 90
Total 182 182

Occupancy %
Adult residential service 88% 96%
Adult community care 98% 100%
Children residental services 65% 89%
Total 78% 93%

Number of properties 85 71
Number of employees 643 568

Childrens Education and Intervention services (FTE) 69 40


Financial highlights


Year to 31 March
2025 (£m

)
Year to 31 March
2024 (£m

)

% increase2025 v 2024
Revenue 31.3 26.4 18.6%
EBITDA 3.6 3.9 (8.0% )
Operating profit 1.8 2.3 (24.3% )



OUR PURPOSE
To provide safe, essential care and support and to improve and enrich the lives of vulnerable children, young people and adults whilst balancing profit, people and planet in all we do.

WHO WE ARE
Tristone Healthcare is a group of businesses that provide the highest quality care and support, throughout the UK, for vulnerable children and adults below retirement age. We are acquiring and growing social care businesses that:

- Provide the highest levels of care and support
- Have demonstrated consistent profitability
- Have demonstrated consistent and strong operational cash flows
- Have quality management teams in place
- Have good relationships with Local Authorities
- Present clear opportunity for growth

Our businesses are constantly striving to be the best providers of care and support within each of their social care categories.


TRISTONE HEALTHCARE LIMITED (REGISTERED NUMBER: 09826810)

GROUP STRATEGIC REPORT
FOR THE YEAR ENDED 31 MARCH 2025

Our Adults Services support people with learning disabilities, those who are recovering from mental illness, people with autistic spectrum disorder, individuals who have one or more physical impairments and provide care and rehabilitation for acquired brain injury. We deliver services in residential, day care and a wide choice of supported living settings.

Our Children's Services provide residential care, specialist education and supported accommodation for young people. We specialise in supporting children and young people with complex needs including those who have been identified with Communication and Interaction needs or Social, Emotional and Mental Health (SEMH) needs for example, as well as victims of criminal exploitation and abuse. Many of the children and young people for whom care and support is provided have significant attachment disorders and present with profound levels of trauma.

OUR GROUP OF BUSINESSES

As at 31 March 2025

Sportfit Support Services Limited
Based in Southampton, Sportfit Support Services Limited offers support and education to young people aged 16 to 19 suffering from developmental delays, abuse and family relationship breakdowns and has recently opened its first Residential Childrens Home.

Premier Care Management Limited
Premier Care Management Limited provides community and outreach services for vulnerable young people in the South-West.

Procare (Wales) Limited & Bangor Centre for Developmental Disabilities Limited
Procare Wales Limited and Bangor Centre for Developmental Disabilities Limited support children and adults with their work in Applied Behaviour Analysis. They also provide 24-hour community living schemes based in the Conwy and Denbighshire area.

Seaside Care Homes Limited
Based in Clacton-on-Sea, Seaside Care Homes provide both long and short- term residential care to young people with a wide variety of complex health care needs.

Beyond Limits (Plymouth) Limited
Plymouth based CQC registered Beyond Limits was founded in 2011 and specialises in supporting people with learning disabilities, mental health issues and other needs. The business operates across Devon, Cornwall, Somerset, and Dumfries and Galloway

Next Steps Mental Healthcare Limited
Next Steps Mental Healthcare, based in the North-West, was founded in 2015, specialises in providing individuals with chronic and treatment-resistant mental illnesses with a therapeutic home environment to receive the highest quality of residential and nursing care.

South West Intervention Services Limited
SWIS offer 1:1 and 2:1 personalised programs of support to children and young people with varying degrees of need. Services include: short breaks, family support, emergency support, hospital support and alternative education provision. SWIS ensure time is given in the approach to the different packages of support available to ensure there is the right balance of social and emotional support, intervention, and education, for each young person. Further SWIS, is developing its first Residential Childrens Home to be opened later in 2025.

In addition, Tristone Healthcare provides consultancy and support services, for which we charge a monthly fee to Juventas Services Limited.

Since March, at the end of May 2025, we acquired Serenity Care Homes Limited. Incorporated in 2021, Serenity Care Homes provides care and support for children across two residential homes in Hampshire.





TRISTONE HEALTHCARE LIMITED (REGISTERED NUMBER: 09826810)

GROUP STRATEGIC REPORT
FOR THE YEAR ENDED 31 MARCH 2025

CEO STATEMENT
Welcome to the Tristone Healthcare annual report for 2025.

The past year has seen us navigating a landscape that continues to challenge the UK social care sector, marked by economic headwinds, regulatory evolution, and workforce wage pressures.

It also marks a period where we have invested significantly in opening more services as demand for high quality children and adults care provision continues. We have been focussed on reinvesting heavily into creating more provision to support long-term, sustainable growth and high-quality care.

Many of these services have only become operational after FY25 year-end yet the operational and capital expenditure associated with launching such services has been largely borne in FY25.

This is important context as we consider the overall group performance. Revenue increased 18.5% from £26,408,359 to £31,298,784, a consequence of the organic growth and increase in placement capacity originated in FY24.

As a result of investing £1.33m into new services and infrastructure, EBITDA decreased by 8% from £3.9m to £3.6m.

This commitment to investing in our portfolio and their services will continue. To further demonstrate this commitment our shareholders invested £1.0m of additional equity during the year. Our businesses are continuously striving to provide better services, services that every individual we serve is deserving of.

In FY2025, we continued our commitment to tracking the social impact the group generates and, as in previous years, utilised the Impact Evaluation Standard to establish the social value contribution. Having generated over £6m of social value last year I am pleased to say that in FY25 we generated a further £4.6m.

In closing, I want to extend my deepest gratitude to our colleagues who work tirelessly and go above and beyond to make a real difference to people's lives.



OUR EMPLOYEES

We continue to develop our community mentality in the business and engage all staff in understanding our mission and values. This includes the development of new awards for staff, based on our fundamental principles. These are our 'Gemstone Awards,' and they recognise exceptional service to the people that we support. We give these awards in different categories:

-Integrity Gemstone
-Compassion Gemstone
-Growth & Collaboration Gemstone
-Doing The Right Thing Gemstone
-Effective Safeguarding Gemstone
-Care Gemstone

There have been some amazing examples of outstanding practice that goes well above any expected levels of care and these are suitably acknowledged and rewarded.

This year we increased our staff count from 568 to 643. Our staff stability index remained stable averaging circa 75% for the year, which given the challenges in recruitment in the sector we are very pleased with this. Our culture committees in each business continue to provide feedback forums, considering employee survey results, and ensuring actions are tailored to local needs and styles. This approach remains vital for us to continue to be a reflective, learning organisation.

SOCIAL IMPACT


TRISTONE HEALTHCARE LIMITED (REGISTERED NUMBER: 09826810)

GROUP STRATEGIC REPORT
FOR THE YEAR ENDED 31 MARCH 2025

The Tristone community takes its social impact extremely seriously. Charitable initiatives appropriate to the current size of the group, are undertaken by community businesses and we are developing our actions in response to climate change and how we can build such actions into our day-to-day operations. These are at an early stage but are a strategic objective for Tristone over the coming years. We are developing our systems to capture and measure our social impact and will seek to disclose our results in due course.

Tristone Healthcare started tracking social value metrics in 2023. The metrics are based upon the Impact Evaluation Standard (IES). These are aligned with government's Social Value Model, and the resulting themes, metrics and proxy values provide an evidence based framework to measure and evidence social value contributions. Thus far, the Tristone community has achieved over £6m in social value through job creation, professional development opportunities and contributions towards the green recovery and charitable initiatives. This is important both strategically and ideologically. Strategically, capturing social value metrics enable us to demonstrate increased Value for Money regarding public expenditure. Crucially, it means we are more likely to achieve success in tendering opportunities with commissioning authorities who must comply with the Public Services (Social Value) Act 2012. Ideologically, we are able to demonstrate a commitment to improving the lives and experiences of people beyond the immediate scope of our services and provisions.

Tristone's Net-Zero Strategy was launched in the summer of 2024. As consistent with Manchester City Council, we aim to achieve net-zero by 2038. This has been considered in terms of the practical and realistic conditions of change required against the need to maintain and sustain growth and profitability. Careful consideration has been afforded to our 2038 target, which has been based upon existing and future technologies and an increasing awareness of the need to act responsibly and decisively in the face of the climate emergency.

Capturing social value and embarking upon a carefully articulated net-zero strategy is part of a wider commitment to developing a strong Environmental, Social and Governance (ESG) proposition. ESG offers value creation through supporting top-line growth through improved optics in relation to stronger community and local government relations, cost reductions through reductions in energy consumption for example, as well as productivity uplift and investment and asset optimisation. The latter points should result in enhanced investment returns through better - more efficient - capital allocation resulting in longer-term gain.


PRINCIPLE RISKS AND MITIGATION STRATEGIES

The Board of Directors carefully monitor and regularly review a range of risks relevant to the whole group. The principal risks and mitigation strategies at the date of this report (not listed in any particular order) are:

1) Safeguarding breaches. Given the nature of the services that the group provides, an ever-present risk is that a safeguarding breach leads to the harm of either an individual accessing support and/or care or of an employee working in our services.

Risk response: Safeguarding our service users and employees is at the very core and forefront of everything we do. This leads our culture, our strategic thinking, and all decision-making. It is the first thing on all formal meeting agendas and we monitor incidents very closely however benign they may appear. It is the primary responsibility of all operational employees and we employ significant resources in its real life practice. We do not compromise on safeguarding leading the way in all our actions. Legislation is unequivocal in the expectation that the welfare of vulnerable people is paramount, and we take this responsibility extremely seriously. To augment our commitment to safeguarding, we have created an Independent Safeguarding Board (ISB) to analyse safeguarding practice, conduct regular reviews of our businesses, and provide lessons learned from any incident. The ISB sits separately and independently from our Board of Directors and comprises sector leading, highly experienced individuals to provide best in class oversight of our practices.

2) Serious accident of a service user or an employee. Closely linked to safeguarding breaches our service users and employees live and work in our freehold and leasehold properties. There is therefore a heightened need to ensure that health and safety policies and procedures are of the highest priority to prevent accidents and injuries. In addition to the impact on the individual, serious events of this type can lead to significant financial, legal, and reputational impact.


TRISTONE HEALTHCARE LIMITED (REGISTERED NUMBER: 09826810)

GROUP STRATEGIC REPORT
FOR THE YEAR ENDED 31 MARCH 2025

Risk response: Health and safety practices are fundamentally and intrinsically embedded into our safeguarding practices and are not separable. We utilise a highly effective health and safety on-line system to monitor compliance and ensure comprehensive property inspections take place on a routine basis. We monitor and investigate all accidents and incidents to ensure lessons are always learned.

3) Coronavirus (Covid 19). The now on-going nature of Covid 19 in our wider society means that its presence in our services is largely unavoidable. However, there remains a risk of a severe reaction to the virus in service-users and high levels of sickness in our employee community.

Risk response: All businesses follow appropriate local advice to reduce transmission. High quality agency staff are made available to cover sickness levels where required.

4) Regulation breaches. Many of our services are already covered by Ofsted, CQC or CIW bodies and regulation is now in place for the provision of support accommodation for young people aged 16-18. Aside from the all-important human impact of providing a substandard service to the people in our care (covered by risks 1 and 2 above) a breach of those regulations resulting in a downgrade of regulatory outcomes could give rise to reputational concerns impacting contract renewal or growth.

Risk response: All services (regulated or otherwise) are designed and run to target the highest level of regulated outcomes. Our safeguarding culture is set to expect those standards. Leadership teams are highly experienced and targeted to meet those standards. We target significant resources at strong corporate governance throughout the community and at present this includes monitoring and planning for the forthcoming regulation of supported accommodation services for young people aged 16-18.

5) Breach of funding facility covenants. The group's existing debt facilities have a series of covenants requiring compliance. They are typical to long-term debt facilities of this nature although are less onerous that those of more traditional bank facilities. A breach of any one covenant would technically give Duke Capital the opportunity to accelerate the repayment of the Duke facility.

Risk response: The group budgets and re-forecasts its financial performance on a regular basis to ensure that all plans continue to keep the group within its covenant obligations. Clear delegated authorities to community businesses mean that all material decision making is held by Directors of Tristone Healthcare to facilitate that monitoring of covenant limitations to ensure compliance.

6) Cyber risk: data security breach / information systems compromise. Common for most modern-day businesses, data management and analysis are central to the successful operation of the Tristone community of businesses. It is again linked closely to safeguarding principles for our service users. A breach of our data security systems could give rise to financial and reputational losses as well as representing a serious safeguarding breach.

Risk response: The group employs a range of data security measures utilising the assistance of an external expert IT security business. Regular penetration tests are carried out to identify and then respond to security weaknesses. And regular IT security training exercises for our employees are used to enhance human decision making and reduce that greatest threat to our systems.

7) Failure to successfully integrate acquired businesses into the community. Central to the success of the Tristone community is that acquired businesses are 'on-boarded' successfully into the community. A failure to do so represents not only financial risk (lower return on investment) but also a risk of disengagement across the leadership teams in the community, and a failure to leverage the cross-networking potential of those leadership teams in the successful operation and growth of all our businesses.

Risk response: Utilise targeted project management methodologies and tools to manage a 3-month detailed on-boarding project for each acquisition. This is followed by monthly trading reviews for all community business with wide-ranging agendas to monitor the long-term success of each businesses. Systems are under-development for employee feedback, and surveys to be commenced in 2025 enabling us to monitor and respond to key employee engagement trends.

8) High inflationary environment. The higher-than-normal inflationary environment of the United Kingdom markets we operate in presents an unusually high financial risk of cost inflation significant exceeding price increases.


TRISTONE HEALTHCARE LIMITED (REGISTERED NUMBER: 09826810)

GROUP STRATEGIC REPORT
FOR THE YEAR ENDED 31 MARCH 2025

Risk response: On-going commercially sensible cost control across the businesses together with balanced price management policies working closely with the fee-paying authorities relevant to our service-users.

9) Employee workforce recruitment, retention, and development. Fundamentally at the core of everything we do are stable, high quality and motivated employee teams across our businesses. A failure to retain and develop existing members of our teams presents significant operational and financial risk, and a failure to safely recruit more people into our teams prevents stability and growth.

Risk response: Clear workforce planning strategies in place across the businesses in addition to a leadership academy programme comprising internally delivered training and external 'mini-MBA' programmes for our leaders of the future. A sector-leading employee benefits programme is utilised to promote retention including competitive pay rates set out above living wage minimum levels, and enhanced recruitment systems continue to be developed for implementation in 2023/24.


GROUP FINANCIAL REVIEW

Year to 31 March 2025 Year to 31 March 2024
Revenue £31.3m £26.4m
Operating profit £1.8m £2.3m
Add back:
Depreciation £0.2m £0.2m
Goodwill amortisation £1.6m £1.4m
EBITDA £3.6m £3.9m
EBITDA % of revenue 11.4% 14.7%

Operating profit £1.8m £2.3m
Finance costs (£3.5m ) (£3.1m )
(Loss) before tax (£1.7m ) (£0.8m )
Taxation (£0.1m ) (£0.1m )
(Loss) after tax (£1.8m ) (£0.9m )


As at 31 March 2025 As at 31 March 2024
Annualised revenue £31.3m £26.8m
Annualised EBITDA £3.6m £3.1m
Annualised EBITDA % of Revenue 11.4% 14.9%

Net group liabilities (£3.9m ) (£3.2m )

Gross debt (£21.5m ) (£21.3m )
Cash at bank £0.7m £1.1m
Net debt (excluding deferred
consideration)

(£21m

)

(£20.1m

)
Deferred consideration (£2.3m ) (£2.8m )
Net debt (£23.4m ) (£22.9m )

Property portfolio valuation £8.0m £7.7m

Net debt after property valuation (£15.4m ) (£15.2m )
EBITDA Leverage 4.3 3.8


Revenue in the year to 31 March 2025 was £31.3m (31 March 2024: £26.4m) which represents an 18.6% increase year on year. With no acquisitions in the year to 31 March 2025 this is all organic growth.

Annualised revenue as at 31 March 2024 (annualised by grossing up to 12 months the in-year results of South West Intervention Services Limited to 31 March 2024) shows an increase of 16.7% from £26.8m to £31.3m.

TRISTONE HEALTHCARE LIMITED (REGISTERED NUMBER: 09826810)

GROUP STRATEGIC REPORT
FOR THE YEAR ENDED 31 MARCH 2025


Following the subsequent acquisition of Serenity Care Homes Limited ('Serenity Care') in May 2025, pro forma annualised revenue (excluding further organic growth from the existing businesses from 1 April 2025) has now reached £32.8m.

EBITDA (operating profit with the charges of depreciation and goodwill amortisation added back) is the principal profit metric used by the Tristone Healthcare group. The result for the year to 31 March 2025 is £3.6m (2024: £3.9m). To support the growth from acquisition and organic growth, the group invests in its central infrastructure and therefore it is not possible to accurately provide a split between EBITDA growth driven by acquisition and organic growth.

Significant investment has been made from group results and reserves into organic growth. The EBITDA decline year on year is reported after that investment impact which is £1.33m in the year to March 2025.

Annualised EBITDA is also £3.6m for the year to 31 March 2025 (31 March 2024: £4.0m). Following the acquisition of Serenity Care since 31 March 2023, pro forma annualised EBITDA (excluding further organic growth from the existing businesses from 1 April 2025) has now reached £4.1m.

The activities of the group have been funded by a variety of funding sources in the years to 31 March 2025 and 2024.


On 16 December 2021, Tristone Healthcare Ltd entered into a new strategic funding partnership with Duke Capital (the 'Duke facility'). This provided the group with a £20.0m overall funding facility which was subsequently been increased to a facility of £21.0m in June 2023. The Duke facility is long-term financing, available for 30 years if not repaid earlier.

Of this £19.6m had been drawn by 31 March 2024. In the year to 31 March 2025 a further £0.3m was drawn for investment related activity and therefore, as at 31 March 2025 a total of £19.9m had been drawn from the Duke facility. Therefore, the group retains £1.15m of remaining headroom in the facilities (£21.0m total) available for a variety of uses including organic and acquisition growth and meeting some of the group's deferred consideration commitments.

In the year to 31 March 2023 loan notes were issued as part of the acquisitions of Beyond Limits (Plymouth) Limited and K Bond Healthcare Limited. These total £850,000 and are not due for repayment until 2027. They are therefore shown in long-term debt. In the year to March 2024 the related finance cost was £64,500 (2024: £64,500).

The Duke facility cost £1.3m to raise in December 2021. Of this, £0.4m was the cash cost of raising the £20.0m facility and £0.9m was the fair value of the equity issued to Duke Capital as part of the strategic partnership. The accounting treatment for each element differs. The costs of raising the debt were calculated as £1.2m and are being amortised over 60 months with £0.3m amortised this year (note 5) (£0.2m in the year to 31 March 2024) leaving a remaining £0.5m of unamortised finance costs shown netting off the long-term loans outstanding (note 14). The remaining £0.1m of the facility costs are treated as the cost of issuing equity and were taken to the share premium account.

An element of the equity issued to Duke Capital attracts a preference share dividend in and the year to 31 March 2025 this was £396,000 (2024: £229,000).

During the year to 31 March 2024, an additional debt facility of £1.01m was arranged and drawn relating to property related loans. The cost of raising this debt was £90,000 and this is being amortised over 60 months.

The finance costs of the group therefore represent the costs of the Duke facility, the amortisation of the transaction costs of the debt raises, loan notes interest and preference share dividends (see note 5).

Overall, finance costs have risen from £3.2m in the year to 31 March 2024 to £3.5m in the year to 31 March 2025 driven by the full year effect of the increased use of the Duke facility plus the costs of the loan notes and the new property related loans.

A loss before tax is therefore recorded of £1.7m in the year to 31 March 2025 (2024 loss before tax: £0.8m).


TRISTONE HEALTHCARE LIMITED (REGISTERED NUMBER: 09826810)

GROUP STRATEGIC REPORT
FOR THE YEAR ENDED 31 MARCH 2025

Taxation on those results is a small charge of £62,000 in the year to March 2025 (2024: £65,000 charge). Tristone Healthcare considers that it is important to pay our fair share of corporation tax in the UK and therefore will never use aggressive taxation schemes to minimise our tax expense.

There was therefore a loss after tax of £1.8m in the year to 31 March 2025 (2024: loss of £0.9m). From this, a profit of £0.1m was attributable to non-controlling interests in 2025 (2024: £0.3m). They are the minority interest shareholders of the holding companies of Sportfit Support Services, Procare Wales, Premier Care Management, Beyond Limits (Plymouth) and K Bond Healthcare. Since March 2025 the minority interest in Procare Wales

The effect of the continuing growth investment and acquisition activity during the year is significant on the balance sheet. The group net liabilities position moved from from £3.2m as at 31 March 2024 to £3.9m as at 31 March 2025. The present net liabilities position is the result of cumulative losses recognised during the time spent setting up the group, before any acquisitions were made, and the subsequent goodwill amortisation effect relating to the acquisition investments to date. It does not indicate any short-term liquidity issues. The success of our investment strategy is now evident in the more recent group results both in terms of revenue growth and the underlying EBITDA and cashflow and these results better reflect the current and on-going financial strength of the group.

Properties used in the provision of services are a mixture of leasehold and freehold. A balanced mix of the two is considered an appropriate objective by the Directors. Freehold properties are regularly valued by independent surveyors. The valuation has risen slightly to £8.0m as at 31 March 2025 up from the 31 March 2024 valuation of £7.7m. This follows the acquisition of one further property in the last financial year.

Combining net debt (see below) with the property portfolio valuations gives a view on the debt exposure linked to annualised EBITDA coverage. This "EBITDA leverage" value provides a good indicator of the real leverage of the operating activities of the group. As at 31 March 2024 this multiple was 4.3, increased a little from the multiple of 3.8 the year earlier, but remaining at a sustainable and healthy level.

The high level of growth in the year is also apparent in the consolidated cash flow statement. Cash generated from operations before interest, tax and capital expenditure (see note 1 to the cash flow statement in the accounts) is £2.4m (2024: £3.1m) and this represents 68% of EBITDA (2024: 79% of EBITDA). As the group continues to grow we expect that cash flow conversion % to settle towards 90%.

The lower conversion % also indicate the investment of cash generated by trading operations in growth. Of the increase in other debtors (note 1 to the consolidated cash flow statement) £0.5m is due to investment in organic growth set-up activity (mobilisation asset) during the year (2024: £0.3m).

The cash flow statement also sets out the sources and uses of the acquisition activity for the year. Cash flows from operating activities broadly met the financing and taxation cash commitments of the group. Total investment activity (including acquisitions) in the year to 31 March 2025 was £0.8m and this was met from £0.3m raised from the Duke facility and new property loans. Within this, property investment totalled £0.4m, investment into the acquired businesses (mainly property and IT systems) to support growth was £0.1m.

Total investment in organic growth activity in the year to 31 March 2025 was £2.0m. To support that growth shareholders supported growth by a share issue valued at £1.0m during the year.

Combining all these movements, total cash on the balance sheet therefore reduced by £0.4m in the year to 31 March 2025 (2024: £0.1m).

After the cash flow activity in the year, net debt stood at £23.2m (2024: £22.9m). This comprises cash at bank of £0.7m (2024: £1.1m) partially off-setting gross debt from the Duke facility £19.9m (2024: £19.6m), the loan notes of £0.85m and the property loans of £1.0m. Net debt at 31 March 2024 also includes deferred consideration of £2.3m relating to the acquisition of subsidiaries (2024: £2.8m). The Duke facility debt has a potential 30-year life through to December 2051. The deferred consideration balances of the acquisitions that had completed by 31 March 2025 fall due in instalments through to December 2025 and will be met either through cash generated from operations or from the remaining headroom in the Duke facility.




TRISTONE HEALTHCARE LIMITED (REGISTERED NUMBER: 09826810)

GROUP STRATEGIC REPORT
FOR THE YEAR ENDED 31 MARCH 2025



-

ON BEHALF OF THE BOARD:





P N Ledgard - Director


23 December 2025

TRISTONE HEALTHCARE LIMITED (REGISTERED NUMBER: 09826810)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 31 MARCH 2025


The directors present their report with the financial statements of the company and the group for the year ended 31 March 2025.

PRINCIPAL ACTIVITY
The principal activity of the group in the year under review was that of the provision of residential care and care in the community.

DIVIDENDS
The directors do not recommend dividend payments for the year (2024: £nil).

EVENTS SINCE THE END OF THE YEAR
Information relating to events since the end of the year is given in the notes to the financial statements.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 April 2024 to the date of this report.

Y A Loucopoulos
C Elliott
R Finney
P N Ledgard
A Hibbard

DISCLOSURE IN THE STRATEGIC REPORT
The directors have chosen to disclose certain information in the strategic report, including post balance sheet events, future developments, and engagement with employees.

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Group Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the group and of the profit or loss of the group for that period. In preparing these financial statements, the directors are required to:

- select suitable accounting policies and then apply them consistently;
- make judgements and accounting estimates that are reasonable and prudent;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's and the group's transactions and disclose with reasonable accuracy at any time the financial position of the company and the group and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and the group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the group's auditors are unaware, and each director has taken all the steps that he ought to have taken as a director in order to make himself aware of any relevant audit information and to establish that the group's auditors are aware of that information.

TRISTONE HEALTHCARE LIMITED (REGISTERED NUMBER: 09826810)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 31 MARCH 2025


AUDITORS
The auditors, Harold Sharp Limited, will be proposed for re-appointment at the forthcoming Annual General Meeting.

ON BEHALF OF THE BOARD:





P N Ledgard - Director


23 December 2025

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
TRISTONE HEALTHCARE LIMITED


Opinion
We have audited the financial statements of Tristone Healthcare Limited (the 'parent company') and its subsidiaries (the 'group') for the year ended 31 March 2025 which comprise the Consolidated Income Statement, Consolidated Other Comprehensive Income, Consolidated Balance Sheet, Company Balance Sheet, Consolidated Statement of Changes in Equity, Company Statement of Changes in Equity, Consolidated Cash Flow Statement and Notes to the Consolidated Cash Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the group's and of the parent company affairs as at 31 March 2025 and of the group's loss for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the group in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and the parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The directors are responsible for the other information. The other information comprises the information in the Group Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Group Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Group Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
TRISTONE HEALTHCARE LIMITED


Matters on which we are required to report by exception
In the light of the knowledge and understanding of the group and the parent company and its environment obtained in the course of the audit, we have not identified material misstatements in the Group Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept by the parent company, or returns adequate for our audit have not been received from branches not visited by us; or
- the parent company financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page twelve, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the group's and the parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the group or the parent company or to cease operations, or have no realistic alternative but to do so.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
TRISTONE HEALTHCARE LIMITED


Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

As part of our planning process:
- We enquired of management the systems and controls the company has in place, the areas of the financial statements that are mostly susceptible to the risk of irregularities and fraud, and whether there was any known, suspected or alleged fraud.
- We obtained an understanding of the legal and regulatory frameworks applicable to the company. We determined that the following were most relevant: FRS 102, Companies Act 2006, health and safety, and employment law.
- We considered the incentives and opportunities that exist in the company, including the extent of management bias, which present a potential for irregularities and fraud to be perpetuated, and tailored our risk assessment accordingly.
- Using our knowledge of the company, together with the discussions held with the company at the planning stage, we formed a conclusion on the risk of misstatement due to irregularities including fraud and tailored our procedures according to this risk assessment.

The key procedures we undertook to detect irregularities including fraud during the course of the audit included:
- Identifying and testing journal entries and the overall accounting records, in particular those that were significant and unusual.
- Reviewing the financial statement disclosures and determining whether accounting policies have been appropriately applied.
- Reviewing and challenging the assumptions and judgements used by management in their significant accounting estimates, in particular in relation to amortisation, depreciation, bad debt provision, accrued costs, and deferred consideration.
- Assessing the extent of compliance, or lack of, with the relevant laws and regulations in particular those that are central to the entities ability to continue in operation.
- Testing key revenue lines, in particular cut-off, for evidence of management bias.
- Performing a verification of key assets.
- Obtaining third-party confirmation of material bank balances.
- Documenting and verifying all significant related party and consolidated balances and transactions.
- Reviewing documentation such as the company board minutes, correspondence with solicitors, for discussions of irregularities including fraud.
- Testing all material consolidation adjustments.

Owing to the inherent limitations of an audit, there is an unavoidable risk that we may not have detected some material misstatements in the financial statements even though we have properly planned and performed our audit in accordance with auditing standards. The primary responsibility for the prevention and detection of irregularities and fraud rests with the directors and management.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
TRISTONE HEALTHCARE LIMITED


Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Frederick Norman (Senior Statutory Auditor)
for and on behalf of Harold Sharp Limited
Statutory Auditors and Chartered Accountants
5 Brooklands Place
Brooklands Road
Sale
Cheshire
M33 3SD

23 December 2025

TRISTONE HEALTHCARE LIMITED (REGISTERED NUMBER: 09826810)

CONSOLIDATED INCOME STATEMENT
FOR THE YEAR ENDED 31 MARCH 2025

2025 2024
Notes £    £   

TURNOVER 31,298,784 26,408,359

Cost of sales (20,635,518 ) (16,695,268 )
GROSS PROFIT 10,663,266 9,713,091

Administrative expenses (9,033,325 ) (7,441,928 )
1,629,941 2,271,163

Other operating income 129,651 52,814
OPERATING PROFIT 4 1,759,592 2,323,977

Interest receivable and similar income 5,915 17,361
1,765,507 2,341,338

Interest payable and similar expenses 5 (3,462,833 ) (3,157,162 )
LOSS BEFORE TAXATION (1,697,326 ) (815,824 )

Tax on loss 6 (66,216 ) (64,947 )
LOSS FOR THE FINANCIAL YEAR (1,763,542 ) (880,771 )
Loss attributable to:
Owners of the parent (1,879,017 ) (1,133,130 )
Non-controlling interests 115,475 252,359
(1,763,542 ) (880,771 )

TRISTONE HEALTHCARE LIMITED (REGISTERED NUMBER: 09826810)

CONSOLIDATED OTHER COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 MARCH 2025

2025 2024
Notes £    £   

LOSS FOR THE YEAR (1,763,542 ) (880,771 )


OTHER COMPREHENSIVE INCOME
Revaluation of property - 216,001
Income tax relating to other comprehensive
income

-

-
OTHER COMPREHENSIVE INCOME
FOR THE YEAR, NET OF INCOME TAX

-

216,001
TOTAL COMPREHENSIVE INCOME
FOR THE YEAR

(1,763,542

)

(664,770

)

Total comprehensive income attributable to:
Owners of the parent (1,879,017 ) (917,129 )
Non-controlling interests 115,475 252,359
(1,763,542 ) (664,770 )

TRISTONE HEALTHCARE LIMITED (REGISTERED NUMBER: 09826810)

CONSOLIDATED BALANCE SHEET
31 MARCH 2025

2025 2024
Notes £    £   
FIXED ASSETS
Intangible assets 8 10,943,874 12,349,013
Tangible assets 9 6,688,937 6,429,319
Investments 10 - -
17,632,811 18,778,332

CURRENT ASSETS
Debtors 11 5,333,498 3,421,945
Cash at bank and in hand 700,513 1,129,185
6,034,011 4,551,130
CREDITORS
Amounts falling due within one year 12 (5,939,580 ) (4,817,350 )
NET CURRENT ASSETS/(LIABILITIES) 94,431 (266,220 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

17,727,242

18,512,112

CREDITORS
Amounts falling due after more than one
year

13

(21,046,411

)

(21,029,606

)

PROVISIONS FOR LIABILITIES 18 (598,462 ) (636,595 )
NET LIABILITIES (3,917,631 ) (3,154,089 )

CAPITAL AND RESERVES
Called up share capital 19 116,587 78,125
Share premium 20 1,709,727 748,189
Revaluation reserve 20 187,393 225,469
Retained earnings 20 (6,913,249 ) (5,072,308 )
SHAREHOLDERS' FUNDS (4,899,542 ) (4,020,525 )

NON-CONTROLLING INTERESTS 21 981,911 866,436
TOTAL EQUITY (3,917,631 ) (3,154,089 )

The financial statements were approved by the Board of Directors and authorised for issue on 23 December 2025 and were signed on its behalf by:





P N Ledgard - Director


TRISTONE HEALTHCARE LIMITED (REGISTERED NUMBER: 09826810)

COMPANY BALANCE SHEET
31 MARCH 2025

2025 2024
Notes £    £   
FIXED ASSETS
Intangible assets 8 50,925 73,493
Tangible assets 9 2,239 3,423
Investments 10 222 222
53,386 77,138

CURRENT ASSETS
Debtors 11 19,503,419 17,417,415
Cash at bank 7,970 130,431
19,511,389 17,547,846
CREDITORS
Amounts falling due within one year 12 (3,607,102 ) (2,572,867 )
NET CURRENT ASSETS 15,904,287 14,974,979
TOTAL ASSETS LESS CURRENT
LIABILITIES

15,957,673

15,052,117

CREDITORS
Amounts falling due after more than one
year

13

(19,245,611

)

(18,761,838

)

PROVISIONS FOR LIABILITIES 18 (560 ) (731 )
NET LIABILITIES (3,288,498 ) (3,710,452 )

CAPITAL AND RESERVES
Called up share capital 19 116,587 78,125
Share premium 20 1,709,727 748,189
Retained earnings 20 (5,114,812 ) (4,536,766 )
SHAREHOLDERS' FUNDS (3,288,498 ) (3,710,452 )

Company's loss for the financial year (578,046 ) (490,714 )

The financial statements were approved by the Board of Directors and authorised for issue on 23 December 2025 and were signed on its behalf by:





P N Ledgard - Director


TRISTONE HEALTHCARE LIMITED (REGISTERED NUMBER: 09826810)

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2025

Called up
share Retained Share
capital earnings premium
£    £    £   
Balance at 1 April 2023 78,125 (3,977,253 ) 748,189

Changes in equity
Total comprehensive income - (1,095,055 ) -
Balance at 31 March 2024 78,125 (5,072,308 ) 748,189

Changes in equity
Issue of share capital 38,462 - 961,538
Total comprehensive income - (1,840,941 ) -
Balance at 31 March 2025 116,587 (6,913,249 ) 1,709,727
Revaluation Non-controlling Total
reserve Total interests equity
£    £    £    £   
Balance at 1 April 2023 47,543 (3,103,396 ) 614,077 (2,489,319 )

Changes in equity
Total comprehensive income 177,926 (917,129 ) 252,359 (664,770 )
Balance at 31 March 2024 225,469 (4,020,525 ) 866,436 (3,154,089 )

Changes in equity
Issue of share capital - 1,000,000 - 1,000,000
Total comprehensive income (38,076 ) (1,879,017 ) 115,475 (1,763,542 )
Balance at 31 March 2025 187,393 (4,899,542 ) 981,911 (3,917,631 )

TRISTONE HEALTHCARE LIMITED (REGISTERED NUMBER: 09826810)

COMPANY STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2025

Called up
share Retained Share Total
capital earnings premium equity
£    £    £    £   
Balance at 1 April 2023 78,125 (4,046,052 ) 748,189 (3,219,738 )

Changes in equity
Total comprehensive income - (490,714 ) - (490,714 )
Balance at 31 March 2024 78,125 (4,536,766 ) 748,189 (3,710,452 )

Changes in equity
Issue of share capital 38,462 - 961,538 1,000,000
Total comprehensive income - (578,046 ) - (578,046 )
Balance at 31 March 2025 116,587 (5,114,812 ) 1,709,727 (3,288,498 )

TRISTONE HEALTHCARE LIMITED (REGISTERED NUMBER: 09826810)

CONSOLIDATED CASH FLOW STATEMENT
FOR THE YEAR ENDED 31 MARCH 2025

2025 2024
Notes £    £   
Cash flows from operating activities
Cash generated from operations 1 2,428,038 3,084,720
Interest paid (2,832,748 ) (2,682,714 )
Finance costs paid (396,312 ) (229,074 )
Tax paid (40,850 ) (348,413 )
Net cash from operating activities (841,872 ) (175,481 )

Cash flows from investing activities
Purchase of intangible fixed assets (12,660 ) (26,012 )
Purchase of tangible fixed assets (504,311 ) (221,374 )
Sale of tangible fixed assets (188 ) -
Purchase of subsidiaries (325,000 ) (2,400,362 )
Interest received 5,915 17,361
Net cash from investing activities (836,244 ) (2,630,387 )

Cash flows from financing activities
New loans in year 250,000 1,800,000
New bank loans in the year - 1,010,000
Amount withdrawn by directors (556 ) (545 )
Share issue 1,000,000 -
Costs of raising finance - (89,751 )
Net cash from financing activities 1,249,444 2,719,704

Decrease in cash and cash equivalents (428,672 ) (86,164 )
Cash and cash equivalents at beginning of
year

2

1,129,185

1,215,349

Cash and cash equivalents at end of year 2 700,513 1,129,185

TRISTONE HEALTHCARE LIMITED (REGISTERED NUMBER: 09826810)

NOTES TO THE CONSOLIDATED CASH FLOW STATEMENT
FOR THE YEAR ENDED 31 MARCH 2025


1. RECONCILIATION OF LOSS BEFORE TAXATION TO CASH GENERATED FROM OPERATIONS

2025 2024
£    £   
Loss before taxation (1,697,326 ) (815,824 )
Depreciation charges 1,812,490 1,559,280
Loss on disposal of fixed assets 188 611
Finance costs 3,462,833 3,157,162
Finance income (5,915 ) (17,361 )
3,572,270 3,883,868
Increase in trade and other debtors (2,029,320 ) (871,097 )
Increase in trade and other creditors 885,088 71,949
Cash generated from operations 2,428,038 3,084,720

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts:

Year ended 31 March 2025
31/3/25 1/4/24
£    £   
Cash and cash equivalents 700,513 1,129,185
Year ended 31 March 2024
31/3/24 1/4/23
£    £   
Cash and cash equivalents 1,129,185 1,215,349


3. ANALYSIS OF CHANGES IN NET DEBT

At 1/4/24 Cash flow At 31/3/25
£    £    £   
Net cash
Cash at bank and in hand 1,129,185 (428,672 ) 700,513
1,129,185 (428,672 ) 700,513
Debt
Debts falling due after 1 year (20,544,688 ) (501,723 ) (21,046,411 )
(20,544,688 ) (501,723 ) (21,046,411 )
Total (19,415,503 ) (930,395 ) (20,345,898 )

TRISTONE HEALTHCARE LIMITED (REGISTERED NUMBER: 09826810)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025


1. STATUTORY INFORMATION

Tristone Healthcare Limited is a private company, limited by shares, registered in England and Wales. The company's registered number is 09826810 and its registered office is 5 Brooklands Place, Brooklands Road, Sale, Cheshire M33 3SD.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

The presentation and functional currency is £ sterling.

Basis of consolidation
The consolidated financial statements include the audited accounts of the company and its subsidiaries made up to 31 March 2025. The financial information of the subsidiaries is prepared as of the same reporting date and consolidated using consistent accounting policies. Group inter-company balances and transactions, including any unrealised profits arising from Group inter-company transactions are eliminated in full.

Results of subsidiary undertakings acquired or disposed of during the current and prior financial year were included in the financial statements from the effective date of control or up to the date of cessation of control. The separable net assets of the acquired subsidiary undertakings were incorporated into the financial statements on the basis of fair value as at the effective date of the Group acquiring control.

TRISTONE HEALTHCARE LIMITED (REGISTERED NUMBER: 09826810)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


2. ACCOUNTING POLICIES - continued

Critical accounting judgements and key sources of estimation uncertainty
In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

The estimates and assumptions which have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities are as follows.

Provisions
A provision is recognised in the balance sheet when the entity has a present legal or constructive obligation as a result of a past event, that can be reliably measured and it is probable that an outflow of economic benefits will be required to settle the obligation. Provisions are recognised at the best estimate of the amount required to settle the obligation at the reporting date.

Investments in subsidiaries
Investments in subsidiaries are initially measured at cost and subsequently measured at amortised cost, being the transaction price less any amounts settled and any impairment losses. The directors make estimates as to the carrying value of these assets and provide for them accordingly.

Mobilisation assets
Mobilisation assets relate to the set-up cost of individual income generating units (IGU) and reflect the investment required to bring these IGU to operational status, being when a first service user moves in to the home. These IGU are each residential accommodation capable of providing care for people with complex care needs. All are set up to be capable of long-term accommodation support for their respective service users of between 15 and 25 years.

A 3 to 7 year useful economic life for amortising the mobilisation asset into the P&L result is used to reflect the period of time over which that initial investment is expected to realise financial benefits until further expenditure is likely to be needed to maintain the IG asset at the high standard required

Goodwill
Goodwill arises on the acquisition of subsidiaries and represents the excess of the consideration transferred over the Group's interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the acquiree and the fair value of the non-controlling interest in the acquiree.

Goodwill is being amortised evenly over its estimated useful life of 10 years from date of acquisition.

Other critical accouting judgements and key sources of estimation uncertainty

Depreciation
Depreciation is provided over the estimated useful life of the asset. The directors make estimates as to the length of those useful lives.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

TRISTONE HEALTHCARE LIMITED (REGISTERED NUMBER: 09826810)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


2. ACCOUNTING POLICIES - continued

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Computer software is being amortised evenly over its estimated useful life of five years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Property - 2% on cost and in accordance with the property
Improvements to property - 33% on cost, 25% on reducing balance, 10 years with residual value of 20% and Straight line over 5 years
Plant and machinery - 25% on reducing balance and 15% on reducing balance
Fixtures and fittings - 33% on cost, 25% on reducing balance and 20% on reducing balance
Motor vehicles - 25% on reducing balance and 25% on cost
Computer equipment - 33% on reducing balance, 33% on cost, 25% on cost, 25% on reducing balance and 25% to 50% straight line

Tangible fixed assets are stated at cost less accumulated depreciation and accumulated impairment losses.

At each balance sheet date the group reviews the carrying amount of its tangible fixed assets to determine whether there is any indication that any items have suffered an impairment loss. If any such indication exists, the recoverable amount of an asset is estimated in order to determine the extent of the impairment loss, if any.

If the recoverable amount of an asset is estimated to be less than its carrying amount, the carrying amount of the asset is reduced to its recoverable amount. Impairment loss is recognised as an expense immediately.

Where an impairment loss subsequently reverses, the carrying amount of the asset is increased to the revised estimate of its recoverable amount, to the extent that the increased carrying amount does not exceed the carrying amount that would have been determined (net of depreciation) had no impairment loss been recognised for the asset in prior years. A reversal of an impairment loss is recognised as income immediately.

Property, which consists of freehold and leasehold buildings, is initially recognised at cost and subsequently carried at the revalued amount less accumulated impairment losses.

TRISTONE HEALTHCARE LIMITED (REGISTERED NUMBER: 09826810)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


2. ACCOUNTING POLICIES - continued

Financial instruments
The group has elected to apply the provisions of Section 11 'Basic Financial Instruments' of FRS 102 to all of its financial instruments.

Financial instruments are recognised when the group becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets, which include trade debtors, other debtors, amounts owed by group undertakings, amounts owed by related parties, current asset investments and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method. Financial assets classified as receivable within one year are not amortised.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities, including trade creditors, other creditors, debentures, bank loans, other loans, deferred consideration, amounts owed to group undertakings, and amounts owed to related parties, that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest.

Financial liabilities are derecognised when, and only when, the group's contractual obligations are discharged, cancelled, or they expire.

Derivative financial instruments are recognised at fair value using a valuation technique with any gains or losses being reported in profit or loss. Outstanding derivatives at reporting date are included under the appropriate format heading depending on the nature of the derivative.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Consolidated Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

TRISTONE HEALTHCARE LIMITED (REGISTERED NUMBER: 09826810)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


2. ACCOUNTING POLICIES - continued

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The group operates a defined contribution pension scheme. Contributions payable to the group's pension scheme are charged to profit or loss in the period to which they relate.

Going concern
At 31 March 2025 the Group, which includes the non-controlling interests, had a loss for the financial period of £1,763,542 (2024: £880,771 loss) and net liabilities of £3,917,631 (2024: £3,154,0899). The company is a holding company and as such relies on its investments in its subsidiaries and the support of other group companies to ensure that it has sufficient funds to pay its debts as they fall due.

The directors have reviewed the working capital requirement forecasts and projections for the Group of companies headed up by Tristone Healthcare Ltd for the next twelve months, taking account of reasonably possible changes in trading performance, together with the planned capital investment over that same period. The group is expected to have a sufficient level of financial resources available through operating cash flows and existing borrowing facilities for a period of at least 12 months from approval of these financial statements ("the going concern period").

Consequently, the directors are confident that the Group and the Company will have sufficient funds to continue to meet their liabilities as they fall due for at least 12 months from the date of approval of the financial statements and have therefore prepared the financial statements on a going concern basis.

3. EMPLOYEES AND DIRECTORS
2025 2024
£    £   
Wages and salaries 19,381,264 15,897,576
Social security costs 1,458,951 1,209,758
Other pension costs 403,836 346,823
21,244,051 17,454,157

The average number of employees during the year was as follows:
2025 2024

Directors 5 5
Staff 633 557
638 562

2025 2024
£    £   
Directors' remuneration 451,435 442,280
Directors' pension contributions to money purchase schemes 38,121 37,376

TRISTONE HEALTHCARE LIMITED (REGISTERED NUMBER: 09826810)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


3. EMPLOYEES AND DIRECTORS - continued

Information regarding the highest paid director is as follows:
2025 2024
£    £   
Emoluments etc 155,200 155,600
Pension contributions to money purchase schemes 20,800 20,043

4. OPERATING PROFIT

The operating profit is stated after charging:

2025 2024
£    £   
Hire of plant and machinery 15,639 11,456
Other operating leases 1,502,282 1,128,774
Depreciation - owned assets 244,693 194,825
Loss on disposal of fixed assets 188 611
Goodwill amortisation 1,540,004 1,346,729
Computer software amortisation 27,795 17,726
Auditors' remuneration 107,500 120,000

Auditors remuneration for the non-audit services of accountancy and taxation compliance was £30,000 (2024: £25,000)

5. INTEREST PAYABLE AND SIMILAR EXPENSES
2025 2024
£    £   
Other interest payable 4,829 2,292
Loan note interest 161,384 116,904
Amortised finance costs 277,723 245,374
Loan interest 2,622,585 2,563,518
Preference dividend 396,312 229,074
3,462,833 3,157,162

6. TAXATION

Analysis of the tax charge
The tax charge on the loss for the year was as follows:
2025 2024
£    £   
Current tax:
UK corporation tax 44,349 31,481

Deferred tax 21,867 33,466
Tax on loss 66,216 64,947

TRISTONE HEALTHCARE LIMITED (REGISTERED NUMBER: 09826810)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


6. TAXATION - continued

Reconciliation of total tax charge included in profit and loss
The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The difference is explained below:

2025 2024
£    £   
Loss before tax (1,697,326 ) (815,824 )
Loss multiplied by the standard rate of corporation tax in the UK of 25 %
(2024 - 25 %)

(424,332

)

(203,956

)

Effects of:
Expenses not deductible for tax purposes (44,636 ) (136,514 )
Depreciation in excess of capital allowances 29,809 22,550
Utilisation of tax losses 98,507 -
Amoritsation not allowable 385,001 336,682
Deferred tax movement 21,867 46,185
Total tax charge 66,216 64,947

Tax effects relating to effects of other comprehensive income

There were no tax effects for the year ended 31 March 2025.

2024
Gross Tax Net
£    £    £   
Revaluation of property 216,001 - 216,001

7. INDIVIDUAL INCOME STATEMENT

As permitted by Section 408 of the Companies Act 2006, the Income Statement of the parent company is not presented as part of these financial statements.


TRISTONE HEALTHCARE LIMITED (REGISTERED NUMBER: 09826810)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


8. INTANGIBLE FIXED ASSETS

Group
Computer
Goodwill software Totals
£    £    £   
COST
At 1 April 2024 15,250,046 108,852 15,358,898
Additions 150,000 12,660 162,660
At 31 March 2025 15,400,046 121,512 15,521,558
AMORTISATION
At 1 April 2024 2,989,423 20,462 3,009,885
Amortisation for year 1,540,004 27,795 1,567,799
At 31 March 2025 4,529,427 48,257 4,577,684
NET BOOK VALUE
At 31 March 2025 10,870,619 73,255 10,943,874
At 31 March 2024 12,260,623 88,390 12,349,013

Goodwill arises on the consolidation of the group's acquisitions.

Goodwill of £2,819,525 arising on the acquisition of 100% of Sportfit Support Services Limited is being amortised over 10 years.

Goodwill of £2,727,931 arising on the acquisition of 100% of Procare Wales Limited and its subsidiary Bangor Centre for Developmental Disabilities Limited is being amortised over 10 years.

Goodwill of £881,375 arising on the acquisition of 100% of Premier Care Management Limited is being amortised over 10 years.

Goodwill of £1,336,750 arising on the acquisition of 100% of Seaside Care Homes Limited is being amortised over 10 years.

Goodwill of £4,194,485 arising on the acquisition of 100% of Next Steps Mental Healthcare Ltd is being amortised over 10 years.

Goodwill of £2,109,640 arising on the acquisition of 100% of Beyond Limits (Plymouth) Ltd is being amortised over 10 years.

Goodwill of £1,330,340 arising on the acquisition of 100% of South West Intervention Services Holdings Limited is being amortised over 10 years

TRISTONE HEALTHCARE LIMITED (REGISTERED NUMBER: 09826810)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


8. INTANGIBLE FIXED ASSETS - continued

Company
Computer
software
£   
COST
At 1 April 2024
and 31 March 2025 92,797
AMORTISATION
At 1 April 2024 19,304
Amortisation for year 22,568
At 31 March 2025 41,872
NET BOOK VALUE
At 31 March 2025 50,925
At 31 March 2024 73,493

9. TANGIBLE FIXED ASSETS

Group
Improvements
to Plant and
Property property machinery
£    £    £   
COST OR VALUATION
At 1 April 2024 6,453,999 219,634 158,996
Additions 347,096 29,646 9,458
At 31 March 2025 6,801,095 249,280 168,454
DEPRECIATION
At 1 April 2024 317,726 79,351 136,806
Charge for year 140,638 40,136 4,932
At 31 March 2025 458,364 119,487 141,738
NET BOOK VALUE
At 31 March 2025 6,342,731 129,793 26,716
At 31 March 2024 6,136,273 140,283 22,190

TRISTONE HEALTHCARE LIMITED (REGISTERED NUMBER: 09826810)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


9. TANGIBLE FIXED ASSETS - continued

Group

Fixtures
and Motor Computer
fittings vehicles equipment Totals
£    £    £    £   
COST OR VALUATION
At 1 April 2024 210,993 59,486 188,016 7,291,124
Additions 53,808 5,030 59,273 504,311
At 31 March 2025 264,801 64,516 247,289 7,795,435
DEPRECIATION
At 1 April 2024 160,002 49,795 118,125 861,805
Charge for year 19,461 3,512 36,014 244,693
At 31 March 2025 179,463 53,307 154,139 1,106,498
NET BOOK VALUE
At 31 March 2025 85,338 11,209 93,150 6,688,937
At 31 March 2024 50,991 9,691 69,891 6,429,319

Property includes freehold and leasehold property. At 31 March 2025 property carrying value of £6,342,731 consisted of £6,047,280 freehold land and buildings, £295,451 long leasehold land and buildings.

Freehold property was revalued at 31 March 2022 to its fair value of £5,620,000 by Harry Torrance MRICS and Russell Lane FRICS, of Aitchison Rafferty, who are independent of the company and have experience of valuing similar properties. At 31 March 2024 the directors consider that the market value is not materially different to the carrying value of £6,342,731

If freehold property were included in the balance sheet on an historical cost basis, then the carrying amount would be £3,630,677 with accumulated depreciation of £371,045.

Plant and machinery, improvements to property, fixtures and fittings, computer equipment and motor vehicles are included at cost.

TRISTONE HEALTHCARE LIMITED (REGISTERED NUMBER: 09826810)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


9. TANGIBLE FIXED ASSETS - continued

Company
Computer
equipment
£   
COST
At 1 April 2024 7,725
Additions 1,399
At 31 March 2025 9,124
DEPRECIATION
At 1 April 2024 4,302
Charge for year 2,583
At 31 March 2025 6,885
NET BOOK VALUE
At 31 March 2025 2,239
At 31 March 2024 3,423

10. FIXED ASSET INVESTMENTS

Company
Shares in
group
undertakings
£   
COST
At 1 April 2024
and 31 March 2025 222
NET BOOK VALUE
At 31 March 2025 222
At 31 March 2024 222

The group or the company's investments at the Balance Sheet date in the share capital of companies include the following:

Subsidiaries

THL Investments Limited
Registered office: 5 Brooklands Place, Brooklands Road, Sale, Cheshire M33 3SD
Nature of business: Sub holding company
%
Class of shares: holding
Ordinary 100.00

Direct ownership

TRISTONE HEALTHCARE LIMITED (REGISTERED NUMBER: 09826810)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


10. FIXED ASSET INVESTMENTS - continued

Seaside Care Homes Limited
Registered office: 5 Brooklands Place, Brooklands Road, Sale, Cheshire M33 3SD
Nature of business: Residential care
%
Class of shares: holding
Ordinary 100.00

Indirect ownership

Roundhouse Care Holdings Limited
Registered office: 5 Brooklands PLace, Brooklands Road, Sale, Cheshire, M33 3SD
Nature of business: Dormant
%
Class of shares: holding
Ordinary 100.00

Direct ownership

Tristone PW Holdings Limited
Registered office: 5 Brooklands Place, Brooklands Road, Sale, Cheshire M33 3SD
Nature of business: Sub holding company
%
Class of shares: holding
Ordinary 70.00

Indirect ownership

Procare Wales Limited
Registered office: Kinmel Place, 56-56 Kinmel Street, Rhyl, Denbighshire, LL18 1AR
Nature of business: Care in the community
%
Class of shares: holding
Ordinary 70.00

Indirect ownership

Bangor Centre for Developmental Disabilities Limited
Registered office: Kinmel Place, 56-56 Kinmel Street, Rhyl, Denbighshire, LL18 1AR
Nature of business: Residential care
%
Class of shares: holding
Ordinary 70.00

Indirect ownership

Tristone SSS Holdings Limited
Registered office: 5 Brooklands PLace, Brooklands Road, Sale, Cheshire M33 3SD
Nature of business: Sub holding company
%
Class of shares: holding
Ordinary 76.00

Indirect ownership

TRISTONE HEALTHCARE LIMITED (REGISTERED NUMBER: 09826810)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


10. FIXED ASSET INVESTMENTS - continued

Sportfit Support Services Limited
Registered office: Portman House, 53 Millbrook Road East, Southampton, Hampshire, SO15 1HN
Nature of business: Residential care
%
Class of shares: holding
Ordinary 76.00

Indirect ownership

Tristone PCM Holdings Limited
Registered office: 5 Brooklands Place, Brooklands Road, Sale, Cheshire, M33 3SD
Nature of business: Sub holding company
%
Class of shares: holding
Ordinary 61.00

Indirect ownership

Premier Care Management Limited
Registered office: 1 Grantham Lane, Kingswood, Bristol, BS15 1EU
Nature of business: Residential care
%
Class of shares: holding
Ordinary 61.00

Indirect ownership

Tristone NS Holdings Limited
Registered office: 5 Brooklands Place, Brooklands Road, Sale, Cheshire, M33 3SD
Nature of business: Sub holding company
%
Class of shares: holding
Ordinary 88.00

Indirect ownership

Next Steps Mental Healthcare Limited
Registered office: 5 Brooklands Place, Brooklands Road, Sale, Cheshire, M33 3SD
Nature of business: Residential care
%
Class of shares: holding
Ordinary 88.00

Indirect ownership

Tristone BL Holdings Limited
Registered office: 5 Brooklands Place, Brooklands Road, Sale, Cheshire, M33 3SD
Nature of business: Sub holding company
%
Class of shares: holding
Ordinary 82.00

Indirect ownership

TRISTONE HEALTHCARE LIMITED (REGISTERED NUMBER: 09826810)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


10. FIXED ASSET INVESTMENTS - continued

Beyond Limits (Plymouth) Ltd
Registered office: 5 Brooklands Place, Brooklands Road, Sale, Cheshire, M33 3SD
Nature of business: Long term care
%
Class of shares: holding
Ordinary 82.00

Indirect ownership

Tristone Healthcare Properties Limited
Registered office: 5 Brooklands Place, Brooklands Road, Sale, Cheshire, M33 3SD
Nature of business: Investment company
%
Class of shares: holding
Ordinary 100.00

Direct ownership

Tristone Healthcare Properties 2 Limited
Registered office: 5 Brooklands Place, Brooklands Road, Sale, Cheshire, M33 3SD
Nature of business: Investment company
%
Class of shares: holding
Ordinary 100.00

Direct ownership

South West Intervention Services Holdings Limited
Registered office: 5 Brooklands Place, Brooklands Road, Sale, Cheshire, M33 3SD
Nature of business: Sub holding company
%
Class of shares: holding
Ordinary 100.00

Indirect ownership

South West Intervention Services Limited
Registered office: 5 Brooklands Place, Brooklands Road, Sale, Cheshire, M33 3SD
Nature of business: Care in the community
%
Class of shares: holding
Ordinary 100.00

Indirect ownership


The company's wholly owned subsidiary undertakings are Roundhouse Care Holdings Limited, Tristone Healthcare Properties Limited, Tristone Healthcare Properties 2 Limited and THL Investments Limited. In addition, via its investment in THL Investments Limited, it also indirectly owns shares in companies which are subsidiaries or sub-subsidiaries of THL Investments Limited.

The group has granted put options to the minority shareholders to purchase the remaining share capital of Tristone SSS Holdings Limited, Tristone PW Holdings Limited, Tristone NS Holdings Limited and Tristone BL Holdings Limited, should each minority shareholder wish to exercise that option. The exercise period is generally between 36 and 60 months from date of acquisition.

TRISTONE HEALTHCARE LIMITED (REGISTERED NUMBER: 09826810)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


11. DEBTORS

Group Company
2025 2024 2025 2024
£    £    £    £   
Amounts falling due within one year:
Trade debtors 2,676,835 1,912,538 (8,000 ) (8,000 )
Amounts owed by group undertakings - - 18,767,086 17,031,962
Amounts owed by associates 31,304 207,863 31,304 207,863
Other debtors 320,105 255,282 115,846 4,719
Directors' current accounts 28,316 27,760 28,316 27,760
Tax 10,149 127,915 (12,122 ) 8,294
VAT - - 23,966 65,609
Called up share capital not paid 12,501 12,501 12,500 12,500
Prepayments and accrued income 1,523,875 471,649 544,523 66,708
4,603,085 3,015,508 19,503,419 17,417,415

Amounts falling due after more than one year:
Prepayments and accrued income 730,413 406,437 - -

Aggregate amounts 5,333,498 3,421,945 19,503,419 17,417,415

Included within prepayments are mobilisation assets of £880,392 (2024: £469,953), of which £730,413 is included within debtors greater than one year. An explanation of this asset and its accounting policy is included within note 2 of these financial statements.

Amounts owed by group undertakings are repayable on demand.

12. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Group Company
2025 2024 2025 2024
£    £    £    £   
Trade creditors 825,356 443,386 443,957 169,568
Amounts owed to group undertakings 1,246 - 2,946,487 2,240,545
Amounts owed to associates 30,000 42,000 30,000 42,000
Tax 80,243 63,624 - -
Social security and other taxes 892,736 425,626 63,853 25,985
VAT 126,787 358,033 - -
Other creditors 439,059 365,194 4,447 4,015
Accruals and deferred income 1,199,403 833,237 118,358 90,754
Deferred consideration 2,344,750 2,286,250 - -
5,939,580 4,817,350 3,607,102 2,572,867

Amounts owed to group undertakings are repayable on demand.

TRISTONE HEALTHCARE LIMITED (REGISTERED NUMBER: 09826810)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


13. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR

Group Company
2025 2024 2025 2024
£    £    £    £   
Bank loans (see note 14) 1,010,000 1,010,000 - -
Other loans (see note 14) 20,036,411 19,534,688 19,245,611 18,761,838
Deferred consideration - 484,918 - -
21,046,411 21,029,606 19,245,611 18,761,838

14. LOANS

An analysis of the maturity of loans is given below:

Group Company
2025 2024 2025 2024
£    £    £    £   
Amounts falling due between two and five years:
Preference shares 1,000 1,000 - -
Amounts falling due in more than five years:
Repayable otherwise than by instalments
Bank loans more 5 yrs non-inst 1,010,000 1,010,000 - -
Other loans more 5yrs non-inst 20,499,000 20,249,000 19,649,000 19,399,000
Finance costs (463,589 ) (715,312 ) (403,389 ) (637,162 )
21,045,411 20,543,688 19,245,611 18,761,838

Other loans of £19,649,000 (2024: £19,399,000 ) have a term of 30 years and attract interest at 14.5% per annum, which is charged to the profit and loss account in the period it is incurred.
Financing costs related to the raising of the loan finance are being amortised over 5 years.

Also included within other loans are loan notes 2027 7% (£350,000) and loan notes 2027 8% (£500,000) issued during the prior year to former owners of the subsidiary companies acquired in the prior year. These are unsecured and attract monthly interest of 7% and 8% pa respectively, payable in arrears until they are repaid in 2027.

Preference shares of £1,000 (2024: £1,000 (included within loans), accounted for as debt, have an annual dividend paid defined by organic growth of the group, and are in favour of Duke Capital Limited.

15. LEASING AGREEMENTS

Minimum lease payments fall due as follows:

TRISTONE HEALTHCARE LIMITED (REGISTERED NUMBER: 09826810)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


Group
Non-cancellable
operating leases
2025 2024
£    £   
Within one year 1,494,859 749,177
Between one and five years 2,544,192 953,128
In more than five years 3,211,297 344,604
7,250,348 2,046,909

Operating leases are in respect of properties that the group rent for their clients.

16. SECURED DEBTS

The following secured debts are included within creditors:

Group
2025 2024
£    £   
Bank loans 1,010,000 1,010,000
Other loans 20,499,000 19,399,000
Preference shares 1,000 1,000
21,510,000 20,410,000

On 15 December 2021 the company entered into guarantees in the form of fixed and floating charges over the company's assets along with guarantees provided by its direct and indirect subsidiary companies; Premier Care Management Limited, Tristone PCM Limited, Procare Wales Limited, Bangor Centre for Developmental Disabilities Limited, Sportfit Support Services Limited, Tristone PW Holdings Limited, Roundhouse Care Holdings Limited, Tristone SSS Holdings Limited, Seaside Care Homes Limited (from 2 March 2022), Tristone NS Holdings (from 25 November 2022), Next Steps Mental Healthcare Limited (from 12 December 2022), Tristone BL Holdings Limited (from 10 March 2022), Beyond Limits (Plymouth) Ltd (from 19th April 2022), South West Intervention Services Holdings Limited and South West Intervention Services Limited (from 23 June 2023), Tristone Healthcare Properties Limited (from 14 February 2023), Tristone Healthcare Properties 2 Limited (from 28 August 2023) and THL Investments Limited, to secure the company's borrowings. At 31 March 2025 the amount outstanding in respect of these borrowings was £19,649,000 (2024: £19,399,000). The beneficiary of the securities are Duke Capital Limited.

17. FINANCIAL INSTRUMENTS

GROUP

All financial instruments are held at amortised cost

COMPANY

All financial instruments are held at amortised cost

TRISTONE HEALTHCARE LIMITED (REGISTERED NUMBER: 09826810)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


18. PROVISIONS FOR LIABILITIES

Group Company
2025 2024 2025 2024
£    £    £    £   
Deferred tax 598,462 576,595 560 731

Other provisions - 60,000 - -

Aggregate amounts 598,462 636,595 560 731

Group
Deferred
tax Dilapidation
£    £   
Balance at 1 April 2024 576,595 60,000
Provided during year 21,867 (60,000 )
Business combinations
Balance at 31 March 2025 598,462 -

Company
Deferred
tax
£   
Balance at 1 April 2024 731
Utilised during year (171 )
Balance at 31 March 2025 560

Deferred tax liabilities of £598,462 (2024: £576,595) comprise £598,462 (2024: £576,595) of capital allowances in excess of depreciation.

Dilapidation provision of £Nil (2024: £60,000) are in respect of properties occupied by the group's subsidiary companies.

19. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: £    £   
6,562,500 Ordinary £0.01 104,087 65,625

Allotted and issued:
Number: Class: Nominal 2025 2024
value: £    £   
1,250,000 Ordinary E £0.01 12,500 12,500

TRISTONE HEALTHCARE LIMITED (REGISTERED NUMBER: 09826810)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


19. CALLED UP SHARE CAPITAL - continued

The 4,000 Ordinary E shares remain unpaid at the year end.

Ordinary shares have full voting, dividend and capital distribution (including winding up) rights. They do not have any rights of redemption.

Ordinary E shares are entitled to receive notice of, and to attend any general meeting of the company. They do not have voting rights.

20. RESERVES

Group
Retained Share Revaluation
earnings premium reserve Totals
£    £    £    £   

At 1 April 2024 (5,072,308 ) 748,189 225,469 (4,098,650 )
Deficit for the year (1,879,017 ) (1,879,017 )
Cash share issue - 961,538 - 961,538
Transfer 38,076 - (38,076 ) -
At 31 March 2025 (6,913,249 ) 1,709,727 187,393 (5,016,129 )

Company
Retained Share
earnings premium Totals
£    £    £   

At 1 April 2024 (4,536,766 ) 748,189 (3,788,577 )
Deficit for the year (578,046 ) (578,046 )
Cash share issue - 961,538 961,538
At 31 March 2025 (5,114,812 ) 1,709,727 (3,405,085 )

Share premium is in respect of the shares issued in December 2021 to Duke Capital Limited and Aurium Capital Limited.

Revaluation reserve arises as a result of the revaluation of the group's freehold properties at 31 March 2024.

21. NON-CONTROLLING INTERESTS

2025 2024
£    £   

Brought forward 866,436 614,077
Share of trade during the year 115,475 252,359
Carried forward 981,911 866,436

TRISTONE HEALTHCARE LIMITED (REGISTERED NUMBER: 09826810)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


22. PENSION COMMITMENTS

During the year the group contributed £368,287 (2024: £309,477) to a defined contribution pension scheme. At 31 March 2025 outstanding contributions of £85,669 (2024: £74,810) are included within other creditors

23. ULTIMATE PARENT COMPANY

Tristone Capital Ltd is regarded by the directors as being the company's ultimate parent company.

Tristone Capital Ltd is incorporated in England and its registered office is, 5 Brooklands Place, Brooklands Road, Sale, Cheshire, M33 3SD. Copies of group accounts can be obtained from Companies House.

24. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 March 2025 and 31 March 2024:

2025 2024
£    £   
R Finney
Balance outstanding at start of year 27,760 27,215
Amounts advanced - 545
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 27,760 27,760

Interest is charged on Directors' advances, credits and guarantees at 2% pa 2025 (2024: 2%pa).

25. RELATED PARTY DISCLOSURES

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Transactions between group entities which have been eliminated on consolidation are not disclosed within the financial statements.

TRISTONE HEALTHCARE LIMITED (REGISTERED NUMBER: 09826810)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


25. RELATED PARTY DISCLOSURES - continued

At 31 March 2025 as a result of acquisitions during the year and prior year, the group have £2,344,750 (2024: £2,771,188) in respect of deferred consideration payable to former shareholders of certain subsidiary companies now controlled by the group.

At 31st March 2025 the group have £350,000 loan notes (7%) and £500,000 of loan notes (8%) payable to former shareholders of certain subsidiary companies now controlled by the group. These are due to be repaid in 2027.

At the 31 March 2025 the group owed £1,246 from Tristone Group Limited, the immediate parent company, the company owed £899 of this amount

During the year the group paid £46,665 for rent to a company controlled by a minority shareholder of a subsidiary company

During the year ended 31 March 2025 the company made sales to companies in which the director, Y Loucopoulos, is a director and shareholder, of £180,000 (2024: 288,753). At 31 March 2025 the company was owed the following amounts in respect of those sales:

CFS Care Limited £10,202 (2024: £10,202 )
Dimensions Care Limited £526 (2024: £526)
Juventas Services Limited £1,047 (2024: £177,353)

At 31 March 2025 the company owed £30,000 (2024: £42,000) to YML Holdings Limited, a company owned and controlled by Y Loucopoulos

At 31 March 2025 the company was owed £19,504 (2024: £19,504) by Hathaway House Holdings Limited, a company owned and controlled by Helen Shepherd, a minority shareholder within the group.

Key management personnel are the directors.

26. POST BALANCE SHEET EVENTS

Following the end of the reporting period the group acquired 100% of the share capital of Serenity Care Homes Limited

Following the end of the reporting period, the put option in Tristone PW Holdings LTD has been satisfied, thus the group acquired the remaining minority interest of PW Holdings Limited and assumed 100% control

Following the year end the group issued additional shares to existing shareholders as part of ongoing group financing arrangements

27. ULTIMATE CONTROLLING PARTY

The controlling party is Y A Loucopoulos.